| The Neurologic Oncology Team was created to better respond to the needs of adult and pediatric patients receiving treatment for tumors involving the central nervous system, brain, and spine. The goal is to provide compassionate, high-level management of benign and malignant tumors. The team offers interdisciplinary consultation, advanced diagnostic methods, and treatment planning. The Neuro-Oncology Center specializes in brain and spinal tumors and tumor embolization. The Skull Base Surgery Center includes specialists in pituitary tumors and skull base tumors. Surgery- Raphael Davis, MD, Team Leader and Chair, Department of Neurologic Surgery, and Co-Director, Institute for Advanced Neurosciences
- Michael Egnor, MD, Vice Chair and Director, Pediatric Neurosurgery
- David Fiorella, MD, PhD, Director, Neurointerventional Radiology, and Endovascular Specialist
- Robert Galler, DO, Co-Director, Comprehensive Spine Center
- Frederick Gutman, MD
- Jonathan Raanan, MD
- Arthur Rosiello, MD
- David Schessel, MD, PhD
- Henry Woo, MD, Director, Cerebrovascular and Stroke Center
Neuro-Oncology, Department of Medicine, NeurologyPathologyRadiologyRadiation OncologyMedical Hematology/Oncology Stony Brook offers a comprehensive range of diagnostic, treatment, and follow-up services for patients with cancer, including expedited diagnosis and technologically advanced radiation, surgical, and systemic therapies. See Diagnostics, Treatments & Technologies for more information. - Advanced imaging. Working with the Department of Radiology, the neurologic oncology team uses advanced imaging technology for diagnosis including high-field MRI, MR angiography, MRI spectroscopy, diffusion with MRI, CT scanners with CT angiography and bloodflow, SPECT, and PET scans.
- Advanced techniques. Stony Brook's neurosurgeons use advanced techniques and equipment such as image-guided neuronavigation, microsurgery, interoperative ultrasound, and awake craniotomy with cortical mapping for surgery near sensitive areas of the brain. They also use minimally invasive techniques such as neuroendoscopy; endovascular neurosurgery (which provides preoperative oembolization), intra-arterial delivery of chemotherapy, and intraoperative angiotherapy; minimal-access spinal surgery; and stereotactic radiosurgery.
Our exceptional clinical support services contribute to coordinated care. These include Nutrition Services, Pain Management, Palliative Care/Survivorship & Support, Pharmacy Services, Physical and Occupational Rehabilitation, Therapeutic Yoga, and our Tumor Board. For more information, see Clinical Support Services. Research is a major part of the neurologic oncology program, and several ongoing projects hold promise. One is looking at investigational biologic agents to inhibit growth factors that modify abnormal function of several pathways. This is important because molecular analysis of malignant cells may provide information on the sensitivity of the tumor to a given therapeutic combination in order to predict response, early relapse, and the side effects of cancer treatment. Built upon its previous positive result of intracarotid chemotherapy for brain tumor, the research team is now investigating its combination with novel agents for further improvement. Stony Brook participates in a broad range of cancer clinical trials and basic research. For information, see Innovations & Research in Cancer. For specific clinical trial listings, see our Current Clinical Trials. First to Use New TechnologiesThe Department recently began using new technologies for the treatment of complex cerebrovascular lesions. David Fiorella, MD, who performed the first three transluminal angioplasty and stenting procedures for intracranial atherosclerosis in North America with the Wingspan® Stent System, has continued this work at SBUMC. Dr. Fiorella's primary clinical interests parallel his research, namely treatment of cerebral aneurysms, intracranial atherosclerosis and stroke. In particular, Dr. Fiorella is one of the most experienced in the world in using the Pipeline Embolization Device™ for reconstruction of complex, and in some cases, otherwise untreatable, cerebral aneurysms. |